医疗保险人群中局部区域妇科癌症与盆底疾病的同时手术
本研究为回顾性队列研究,利用SEER-Medicare数据识别2000至2017年诊断的局部或区域子宫内膜癌、宫颈癌和卵巢癌病例,随访5年。30,862例患者中仅5.5%接受同期盆腔器官脱垂-尿失禁(POP-UI)手术;有POP-UI相关诊断者中21.1%接受同期手术;未同期手术但有POP-UI诊断者中5.5%在5年内接受第二次POP-UI手术。
要点
- 局部区域妇科癌症患者中仅5.5%接受同期POP-UI手术。
- 有POP-UI相关诊断者中21.1%接受同期手术。
- 未同期手术但有POP-UI诊断者中5.5%在5年内接受POP-UI手术。
核心结论
- 65岁以上早期妇科癌症合并POP-UI相关诊断患者中同期手术率为21.1%。
- 未接受同期手术但有POP-UI诊断的女性中,每18例有1例在指数癌症手术后5年内接受POP-UI手术。
- 需要专门努力识别最可能从同期癌症和POP-UI手术中获益的局部区域妇科癌症和盆底疾病患者。
研究设计与样本
- 回顾性队列研究,使用SEER-Medicare数据集识别2000至2017年诊断的局部或区域子宫内膜癌、宫颈癌和卵巢癌病例。
- 患者从诊断起随访5年。
- 采用χ²检验识别与子宫切除术同时或子宫切除术后5年内接受POP-UI手术相关的分类变量。
- 采用logistic回归计算经单因素分析中统计学显著(α=.05)变量校正的比值比和95%CI。
主要发现
- 30,862例局部区域妇科癌症患者中,仅5.5%接受同期POP-UI手术。
- 有POP-UI相关诊断的患者中,21.1%接受同期手术。
- 初次癌症手术时有POP-UI诊断且未接受同期手术的患者中,额外5.5%在5年内接受第二次POP-UI手术。
- 同期手术率在该时间段内保持不变(2000年和2017年均为5.7%),尽管同期POP-UI诊断频率增加。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate the rate of concurrent surgery for locoregional gynecologic cancer and pelvic organ prolapse-urinary incontinence (POP-UI) and to assess the rate of surgery for POP-UI within 5 years for those who did not undergo concurrent surgery. METHODS: This is a retrospective cohort study. The SEER-Medicare data set was used to identify cases of local or regional endometrial, cervical, and ovarian cancer diagnosed from 2000 to 2017. Patients were followed up for 5 years from diagnosis. We used χ 2 tests to identify categorical variables associated with having a concurrent POP-UI procedure with hysterectomy or within 5 years of hysterectomy. Logistic regression was used to calculate odds ratios and 95% CIs adjusted for variables statistically significant (α=.05) in the univariate analyses. RESULTS: Of 30,862 patients with locoregional gynecologic cancer, only 5.5% underwent concurrent POP-UI surgery. Of those with a preexisting diagnosis related to POP-UI, however, 21.1% had concurrent surgery. Of the patients who had a diagnosis of POP-UI at the time of initial surgery for cancer and who did not undergo concurrent surgery, an additional 5.5% had a second surgery for POP-UI within 5 years. The rate of concurrent surgery remained constant over the time period (5.7% in 2000 and 2017) despite an increase in the frequency of POP-UI diagnosis in the same time frame. CONCLUSION: The rate of concurrent surgery for patients with an early-stage gynecologic cancer and POP-UI-associated diagnosis in women older than age 65 years was 21.1%. Of women who did not undergo concurrent surgery but had a diagnosis of POP-UI, 1 in 18 underwent surgery for POP-UI within 5 years of their index cancer surgery. Dedicated efforts must be made to identify patients who would most benefit from concurrent cancer and POP-UI surgery in those with locoregional gynecologic cancers and pelvic floor disorders.
引用
- Corey L, Seaton R, Ruterbusch JJ, et al. Concurrent Surgery for Locoregional Gynecologic Cancers and Pelvic Floor Disorders in a Population of Patients With Medicare Insurance. Obstet Gynecol. 2023. PMID: 36897144. doi:10.1097/AOG.0000000000005085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。